Class 12 Biology | Unit VI
Chapter 12: Biotechnology and Its Applications
Agriculture • Medicine • Transgenic Animals • Ethical Issues
1. Biotechnology in Agriculture
1.1 Bt Cotton — Insect-Resistant Crops
Mechanism of Action:
- Bt toxin exists as inactive protoxin crystals (cry proteins) inside the bacterium.
- When insect ingests Bt plant tissue, the alkaline midgut pH dissolves the crystals.
- Gut proteases cleave protoxin → active toxin.
- Active toxin binds midgut epithelial cell receptors → pore formation.
- Pores cause cell swelling and lysis → insect death.
| Bt Toxin Gene | Crop | Target Pest |
|---|---|---|
| cry IAc | Cotton | Cotton Bollworm |
| cry IIAb | Cotton | Cotton Bollworm |
| cry IAb | Corn (Maize) | Corn Borer |
1.2 Pest-Resistant Plants — RNA Interference (RNAi)
Example — Nematode-Resistant Tobacco: Nematode Meloidogyne incognita infests tobacco roots. Scientists introduced a DNA construct (via Agrobacterium) that produces both sense and anti-sense RNA for a nematode-specific gene. These form dsRNA → RISC complex degrades nematode mRNA → nematode cannot survive → plant protected.
1.3 Golden Rice — Biofortification
Developed by Ingo Potrykus & Peter Beyer (1999). Two genes inserted:
- psy (phytoene synthase) — from daffodil (Narcissus pseudonarcissus)
- crtI (carotene desaturase) — from Erwinia uredovora
2. Biotechnology in Medicine
2.1 Recombinant Insulin (Humulin)
Production Steps:
- Genes for Chain-A and Chain-B chemically synthesised.
- Each gene inserted into E. coli plasmid alongside β-galactosidase gene (fusion protein tag).
- Two E. coli batches produce Chain-A and Chain-B separately.
- Chains extracted, purified from β-gal using cyanogen bromide.
- Chains combined in vitro → disulphide bonds form → functional Humulin.
2.2 Gene Therapy
• Somatic: Body cells; changes NOT heritable.
• Germline: Germ cells; changes ARE heritable. Ethically controversial.
• Ex vivo: Cells taken out → modified in lab → returned to patient.
• In vivo: Gene delivered directly into patient using viral vectors.
Classic Example: ADA Deficiency — SCID
- ADA (Adenosine Deaminase) deficiency → SCID (Severe Combined Immunodeficiency). ADA gene on chromosome 20.
- Gene Therapy Steps: Withdraw lymphocytes → introduce functional ADA cDNA via retroviral vector → cultured → infuse back into patient.
- Limitation: Lymphocytes are not immortal → periodic infusions needed. Permanent cure = gene into bone marrow stem cells.
2.3 Molecular Diagnosis
A. PCR (Polymerase Chain Reaction) — invented by Kary Mullis (Nobel 1993). Uses Taq polymerase (from Thermus aquaticus). Three steps per cycle:
- Denaturation (94°C): dsDNA separates into ssDNA.
- Annealing (~55°C): Primers hybridise to complementary sequences.
- Extension (72°C): Taq polymerase synthesises new strand. Amplification = 2n copies after n cycles.
B. ELISA (Enzyme Linked Immunosorbent Assay) — based on antigen–antibody interaction with enzyme-linked colour change. Used for HIV, Hepatitis B, pregnancy.
C. DNA Probe (Autoradiography) — single-stranded DNA/RNA tagged with radioactive molecule hybridises to complementary target sequence; detected by autoradiography.
2.4 Recombinant Therapeutics
| Therapeutic | Used For | Produced By |
|---|---|---|
| Humulin (Insulin) | Diabetes mellitus | E. coli |
| r-Growth Hormone | Pituitary dwarfism | E. coli |
| Alpha-1-antitrypsin | Emphysema | Transgenic sheep (Tracy) |
| Interferon | Viral infections, Cancer | E. coli |
| Erythropoietin | Anaemia (kidney failure) | CHO cells |
| Streptokinase | Blood clots (MI) | Streptococcus |
30+ rDNA therapeutics approved worldwide; 12 in India
3. Transgenic Animals
Uses of Transgenic Animals:
- Normal Physiology & Development: Understanding gene function and regulation (e.g., overexpression of growth hormone in mice).
- Disease Models: Transgenic mice for Cancer, Alzheimer's, Cystic fibrosis, Parkinson's, Rheumatoid arthritis.
- Biological Products (Pharming):
- Cow “Rosie” (1997) → human alpha-lactalbumin at 2.4 g/L of milk.
- Sheep “Tracy” → alpha-1-antitrypsin (treats emphysema).
- Vaccine Safety Testing: Polio vaccine tested in transgenic mice before human trials.
- Chemical Safety / Toxicology: More sensitive; fewer animals needed; faster results.
4. Ethical Issues in Biotechnology
- Biopiracy: Unethical use of biological resources and traditional
knowledge by MNCs without compensation.
- Basmati rice — RiceTec Inc. (USA); revoked 2002.
- Turmeric — wound healing patent; revoked by showing prior art.
- Neem — W.R. Grace biopesticide; EPO revoked 2000.
- GMO Safety: Long-term impact on health, biodiversity, ecosystems.
- Patenting Life Forms: Should genes/organisms be patented?
- Germline Gene Therapy: Heritable modifications — consent of future generations.
• GEAC (Genetic Engineering Approval Committee) — MoEFCC — approves GMO safety for public release.
• RCGM (Review Committee on Genetic Manipulation) — DBT — regulates ongoing GM research.
• Biological Diversity Act, 2002 — protects India's bio-resources and traditional knowledge.
🎓 Key NEET Questions (Previous Years)
Answer: (b) The Bt toxin exists as an inactive protoxin crystals in the bacterium. It is only activated by the alkaline pH and proteases of the insect midgut.
Answer: (b) First gene therapy (1990, W.F. Anderson) for ADA deficiency (SCID). ADA cDNA introduced into lymphocytes via retroviral vector.
Answer: (c) Genetic Engineering Approval Committee — under Ministry of Environment, Forest and Climate Change. Approves safety of GMOs for public use in India.
Answer: (c) Transgenic cow Rosie produces human alpha-lactalbumin at 2.4 g/L. Transgenic sheep Tracy produces alpha-1-antitrypsin.
Answer: (b) Humulin (recombinant human insulin) produced by Eli Lilly using rDNA technology in E. coli (1983). First licensed rDNA drug.
💡 Rapid Revision — Key Numbers
- Humulin licensed: 1983 | Company: Eli Lilly
- Insulin: Chain A = 21 aa | Chain B = 30 aa
- Rosie (cow): 2.4 g/L human alpha-lactalbumin in milk
- Transgenic animals: 95% are mice | First: 1974 (Rudolf Jaenisch)
- rDNA therapeutics: 30+ worldwide | 12 in India
- Golden Rice: β-carotene in endosperm | genes from daffodil + Erwinia
- First gene therapy: 1990 | W.F. Anderson | ADA-SCID
- RNAi Nobel Prize: 2006 | Andrew Fire & Craig Mello
CLASS 12 BIOLOGY | NCERT SOLUTIONS
Chapter 12 — Biotechnology and Its Applications
All NCERT Exercise Questions with Detailed Solutions | CBSE Marking Scheme
NCERT Exercise Questions & Solutions
(a) bacteria are resistant to toxin (b) toxin is immature and inactive (c) bacteria lack receptors for toxin (d) toxin is only active in alkaline pH
In Bacillus thuringiensis, the Bt toxin exists as an inactive protoxin enclosed in protein crystals. It only becomes biologically active when it enters the alkaline midgut pH of an insect, where proteases cleave it into the active form. The active toxin then binds epithelial receptors, creating pores → cell lysis → insect death. The bacterium itself has no such alkaline midgut environment.
Transgenic bacteria are bacteria whose genome has been altered by introducing a foreign gene from another organism using rDNA technology, enabling them to produce a new protein of commercial or therapeutic value.
Example — Production of Humulin by E. coli:
The genes for insulin Chain-A and Chain-B were chemically synthesised and inserted into E. coli plasmids (along with β-galactosidase gene as fusion tag). Two separate batches of transgenic E. coli produce Chain-A and Chain-B. Chains are then extracted, purified, and combined in vitro to form functional human insulin — Humulin (Eli Lilly, 1983). This was the first licensed rDNA drug.
| Advantages | Disadvantages |
|---|---|
| Increased yield and productivity | May harm non-target organisms |
| Reduced chemical pesticide use (Bt crops) | Potential gene flow → superweeds |
| Tolerance to abiotic stresses | Reduced biodiversity (monoculture) |
| Enhanced nutrition (Golden Rice) | Ethical concerns / biopiracy |
| Post-harvest loss reduction | Unknown long-term health effects |
| Resistance to diseases and pests | Terminator seeds — farmers cannot save seeds |
Cry Proteins (Crystal proteins) are insecticidal proteins produced by Bacillus thuringiensis and encoded by cry genes. They are stored as inactive protoxin crystals within bacterial spores.
How man exploits Cry proteins:
- Biopesticide sprays: Cry toxin spores sprayed as eco-friendly alternative to chemical pesticides.
- Bt Transgenic Crops: cry gene inserted into crops:
- cryIAc / cryIIAb → Bt cotton (resists cotton bollworm)
- cryIAb → Bt corn (resists corn borer)
- Result: Lower pesticide costs, less pollution, protection of non-target organisms.
Gene therapy is a collection of methods to correct a genetic defect by delivering a functional copy of the defective gene into the cells of an individual using a suitable vector.
Illustration — ADA Deficiency & Gene Therapy:
- Disease: ADA (Adenosine Deaminase) deficiency → SCID (both T and B lymphocytes non-functional).
- Cause: Deletion of ADA gene on chromosome 20.
- Gene Therapy Steps (Ex-vivo):
- Withdraw lymphocytes from patient's blood.
- Introduce functional ADA cDNA into lymphocytes via retroviral vector.
- Multiply engineered lymphocytes in culture.
- Infuse back into patient → produce ADA enzyme → immune function restored.
- Limitation: Lymphocytes are not immortal → periodic re-infusion needed.
- Permanent cure: Introduce ADA gene into bone marrow stem cells at early embryonic stage.
Steps in cloning and expressing a gene in E. coli:
- mRNA Isolation: Isolate mRNA from reticulocytes (cells that express β-globin gene).
- cDNA Synthesis: Use reverse transcriptase to convert mRNA → cDNA (avoids introns).
- Vector Insertion: Cut cDNA and expression vector (e.g., pBR322) with same restriction enzyme → ligate with DNA ligase. Include promoter for E. coli expression.
- Transformation: Introduce recombinant plasmid into competent E. coli (heat shock / electroporation).
- Selection: Select transformed colonies via antibiotic resistance or blue-white screening.
- Expression: E. coli transcribes and translates inserted gene → β-globin protein produced.
- Purification: Isolate and purify the expressed protein.
[Diagram: gene → restriction cut → ligation into plasmid → transformation → selection → culture → protein]
Using the principle of RNAi, oil content in seeds can be reduced by silencing oil biosynthesis genes:
- Identify target gene: The gene encoding key fatty acid synthesis enzyme (e.g., fatty acid desaturase).
- Construct RNAi vector: Insert the target gene in both sense and anti-sense orientation in a plant expression vector.
- Transform plant: Introduce via Agrobacterium or biolistics.
- Silencing: In transformed seeds, both sense and anti-sense RNA are produced → form dsRNA → RISC complex activated → target mRNA degraded.
- Result: Oil-synthesis enzyme not produced → significantly reduced oil/hydrocarbon content in seeds.
Transgenic animals: Animals whose DNA has been experimentally altered to contain and express a foreign gene in all their somatic and germ cells.
Applications:
- Normal Physiology & Development: Studying role of specific genes in body development.
- Disease Models: Mice for Cancer, Alzheimer's, Cystic fibrosis, Parkinson's — study pathology and test drugs.
- Biological Products (Pharming): Rosie (cow) → human alpha-lactalbumin (2.4 g/L); Tracy (sheep) → alpha-1-antitrypsin.
- Vaccine Safety Testing: Polio vaccine tested in transgenic mice before human use.
- Toxicology Testing: More sensitive animals; fewer animals needed; faster results.
Biopiracy: Unethical use and patenting of biological resources and traditional knowledge of indigenous communities by MNCs without proper authorisation, acknowledgement, or compensation.
Indian Examples:
- Basmati rice: RiceTec Inc. (USA) — most claims revoked 2002.
- Turmeric: Wound-healing patent — revoked by showing Sanskrit prior art.
- Neem: W.R. Grace biopesticide — EPO revoked 2000.
- Protect sovereign rights of nations over bio-resources (CBD, 1992).
- Ensure fair benefit-sharing with indigenous communities.
- Prevent monopolisation by developed-nation corporations.
- Maintain economic justice and recognise IPR of traditional knowledge holders.
- India: Biological Diversity Act, 2002 + Patents Amendment Act, 2005.
PCR (Polymerase Chain Reaction) is a technique for amplifying specific DNA sequences in vitro exponentially. Developed by Kary Mullis (Nobel Chemistry, 1993).
Steps (repeated 30–35 cycles):
- Denaturation (94°C): dsDNA separates into two ssDNA strands.
- Annealing (~55°C): Specific primers hybridise to complementary sequences on each strand.
- Extension (72°C): Taq DNA polymerase extends primer → new complementary strand synthesised.
Why "Polymerase Chain Reaction"? Because it uses DNA polymerase (Taq polymerase) repetitively in a chain of thermal cycles, each cycle producing products used as templates for the next — creating an exponential chain-like amplification.
Q1: 1 mark | Q2: 2 marks | Q3: 3 marks | Q4: 3 marks | Q5: 5 marks | Q6: 5 marks | Q7: 3 marks | Q8: 3 marks | Q9: 5 marks | Q10: 3 marks
CLASS 12 BIOLOGY | NEET RAPID CAPSULE
Facts & High-Yield Points
Chapter 12 — Biotechnology and Its Applications | 25 Key Facts for NEET
Tracy (sheep) → alpha-1-antitrypsin — therapeutic (emphysema).
🧠 Mnemonics — Remember Fast
📊 NEET Comparison: PCR vs ELISA vs DNA Probe
| Feature | PCR | ELISA | DNA Probe |
|---|---|---|---|
| Detects | DNA / RNA sequences | Antigens / Antibodies | Specific DNA sequences |
| Principle | DNA amplification | Antigen-antibody + enzyme | Hybridisation |
| Label | None (gel electrophoresis) | Enzyme (colorimetric) | Radioactive molecule |
| Detection | Gel bands | Colour change | Autoradiography |
| HIV use | RT-PCR (very early) | Antibody (later) | Rarely used |
